Litcius/Paper detail

Michael addition-driven synthesis of cytotoxic palladium(<scp>ii</scp>) complexes from chromone thiosemicarbazones: investigation of anticancer activity through<i>in vitro</i>and<i>in vivo</i>studies

Jebiti Haribabu, Nithya Balakrishnan, Srividya Swaminathan, Dorothy Priyanka Dorairaj, Mohammad Azam, Mohamed Kasim Mohamed Subarkhan, Yu‐Lun Chang, Sodio C. N. Hsu, Pavel Štarha, Ramasamy Karvembu

2023New Journal of Chemistry33 citationsDOI

Abstract

Michael addition derived Pd( ii ) complexes exhibited potential anticancer activity in HeLa cells via apoptosis. In vivo models showed that the complexes did not cause any harm to the treated mice, portraying better selectivity than cisplatin.

Topics & Concepts

ChemistryChromoneHeLaIn vivoIn vitroCytotoxic T cellCisplatinApoptosisSemicarbazoneStereochemistryPharmacologyBiochemistryChemotherapyInternal medicineMedicineBiologyBiotechnologyMetal complexes synthesis and propertiesSynthesis and biological activitySynthesis of Organic Compounds
Michael addition-driven synthesis of cytotoxic palladium(<scp>ii</scp>) complexes from chromone thiosemicarbazones: investigation of anticancer activity through<i>in vitro</i>and<i>in vivo</i>studies | Litcius